Sanofi plucks new CSO from in-stealth biotech
WEB3 days ago · After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, taking up the top science spot at Sanofi. Quigley will start Sept. 30 as the French Big Pharma’s chief...
Sanofi names new chief scientific officer amid push to redefine
WEB3 days ago · In an internal memo obtained by STAT, Sanofi said Monday that it has named Mike Quigley, formerly the CEO of startups Dualitas Therapeutics and Therini Bio and senior vice president of...
BioCentury - Sanofi names Mike Quigley CSO
WEB3 days ago · Mike Quigley will become CSO and global head of research at Sanofi (Euronext:SAN; NASDAQ:SNY) on Sept. 30, a company spokesperson confirmed to BioCentury.
Sanofi hires Mike Quigley as next chief scientist, internal memo …
WEB3 days ago · Sanofi has appointed Mike Quigley, a former executive at Gilead and Bristol Myers Squibb, as the French pharma’s next chief scientific officer, Endpoints News ...
Readout Newsletter: 23andMe, Amgen, Sanofi, etc. - STAT
WEB2 days ago · Sanofi named a new chief scientific officer: Mike Quigley, formerly the CEO of startups Dualitas Therapeutics and Therini Bio and senior vice president of research biology at Gilead.
Endpoints News — Wave’s stock soars on new DMD biomarker data; Sanofi ...
WEBSanofi has appointed Mike Quigley, a former executive at Gilead and Bristol Myers Squibb, as the French pharma's next chief scientific officer, Endpoints News has learned....
STAT on LinkedIn: Amid push to redefine itself, Sanofi names new …
WEBMike Quigley, who was formerly the CEO of startups Dualitas Therapeutics and Therini Bio and an executive at Gilead, will now take over at Sanofi.
Biotech Networks on LinkedIn: Scoop: Sanofi hires Mike Quigley …
WEBSFBN Trending News: Scoop: Sanofi hires Mike Quigley as next chief scientist, internal memo says https://lnkd.in/gMMjJS2W Sanofi has appointed Mike Quigley, a former executive at Gilead and...
Gilead poaches Bristol-Myers oncology executive to lead research ...
WEBFeb 19, 2020 · Gilead Sciences has a new head of research biology: Michael Quigley, Ph.D., an alum of MedImmune, Johnson & Johnson and the Dana-Farber Cancer Institute, who joins from Bristol-Myers Squibb ...
Michael QUIGLEY | President & Chief Scientific Officer | Ph.D ...
WEBMichael QUIGLEY, President & Chief Scientific Officer | Cited by 2,702 | | Read 43 publications | Contact Michael QUIGLEY
- Some results have been removed